Mirikizumab improves bowel movement urgency in ulcerative colitis

AUSTIN, Texas —  Patients with moderately to severely active ulcerative colitis experienced improvements in bowel movement urgency after receiving mirikizumab, according to research presented at the Crohn’s and Colitis Congress.Marla Dubinsky, MD, of the Icahn School of Medicine at Mount Sinai, told Healio Gastroenterology and Liver Disease that urgency is commonly reported by patients with UC and has a significant impact on their lives.“[Urgency] is the symptom that’s keeping people up at night or keeping people away from their work,” she said. “UpRead More

Share on facebook
Share on twitter
Share on linkedin